Achillion Pharmaceuticals Probability of Future Pink Sheet Price Finishing Over 0.0
Achillion Pharmaceuticals' future price is the expected price of Achillion Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Achillion Pharmaceuticals performance during a given time horizon utilizing its historical volatility. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
Please specify Achillion Pharmaceuticals' target price for which you would like Achillion Pharmaceuticals odds to be computed.
Achillion |
Achillion Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Achillion Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Achillion Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Achillion Pharmaceuticals is not yet fully synchronised with the market data | |
| Achillion Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Achillion Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Achillion Pharmaceuticals currently holds 61 K in liabilities with Debt to Equity (D/E) ratio of 1.0, which is about average as compared to similar companies. Achillion Pharmaceuticals has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Achillion Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Achillion Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Achillion Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Achillion to invest in growth at high rates of return. When we think about Achillion Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 8.7 K. Net Loss for the year was (51 K) with profit before overhead, payroll, taxes, and interest of 7.87 K. | |
| Achillion Pharmaceuticals currently holds about 1.44 K in cash with (39.76 K) of positive cash flow from operations. | |
| Roughly 98.0% of Achillion Pharmaceuticals shares are held by company insiders |
Achillion Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Achillion Pink Sheet often depends not only on the future outlook of the current and potential Achillion Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Achillion Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Float Shares | 716.88k | |
| Average Daily Volume Last 10 Day | 138 | |
| Average Daily Volume In Three Month | 72 |
Achillion Pharmaceuticals Technical Analysis
Achillion Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Achillion Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Achillion Pharmaceuticals. In general, you should focus on analyzing Achillion Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Achillion Pharmaceuticals Predictive Forecast Models
Achillion Pharmaceuticals' time-series forecasting models is one of many Achillion Pharmaceuticals' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Achillion Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Achillion Pharmaceuticals
Checking the ongoing alerts about Achillion Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Achillion Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Achillion Pharmaceuticals is not yet fully synchronised with the market data | |
| Achillion Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Achillion Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Achillion Pharmaceuticals currently holds 61 K in liabilities with Debt to Equity (D/E) ratio of 1.0, which is about average as compared to similar companies. Achillion Pharmaceuticals has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Achillion Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Achillion Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Achillion Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Achillion to invest in growth at high rates of return. When we think about Achillion Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 8.7 K. Net Loss for the year was (51 K) with profit before overhead, payroll, taxes, and interest of 7.87 K. | |
| Achillion Pharmaceuticals currently holds about 1.44 K in cash with (39.76 K) of positive cash flow from operations. | |
| Roughly 98.0% of Achillion Pharmaceuticals shares are held by company insiders |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in Achillion Pink Sheet
If you are still planning to invest in Achillion Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Achillion Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |